HX630
HX630 is a potent retinoic acid X receptor (RXR) agonist, can induce apoptosis, has anti-tumor effect, and can be used in Cushing's disease research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 188844-52-2
- Fòrmula: C28H27NO2S
- Peso molecular:441.58
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
HX630 (0.1-10 μM, 96 h) can dose-dependently inhibit cell proliferation and induce apoptosis of AtT20 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:AtT20 cells
-
Concentration:0.1, 1, 5, 10 μM
-
Incubation Time:96 h
-
Result:Significantly inhibited AtT20 cell proliferation at 10 μM.
Decreased Pomc mRNA expression and ACTH secretion in a dose-dependent manner.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female BALB/c-nu mice (nu/nu) with AtT20 cells[1]
-
Dosage:5 mg/kg
-
Administration:i.p., 3 times a week for 3 weeks
-
Result:Significantly reduced tumor volume and Pomc mRNA expression in tumor cells, but body weight and plasma ACTH levels were not significantly different.
Chemical Information
-
No. CAS 188844-52-2
-
Peso molecular 441.58
-
Fòrmula C28H27NO2S
-
SMILES
O=C(O)C1=CC=C(C(C2=C3)=NC4=CC=CC=C4SC2=CC5=C3C(C)(C)CCC5(C)C)C=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)